Home » Newsletters » BioWorld

BioWorld

Oct. 5, 1994

View Archived Issues

DARWIN MOLECULAR COULD GET $16.5M FROM RHONE- POULENC

BTG PLACES SHARES, LOSES PAYMENT

SUGEN COMPLETES IPO, NETS $18M

SEPRACOR PLACEMENT RAISES $5M

`MAGIC BULLET' REVISITED INTERFERON MAKING COMEBACK AS POTENTIAL

INTERLEUKIN ADJUVANTS ADVANCE TO NEW HUMAN TRIALS

ZYNAXIS CUTS STAFF 25 PERCENT IN RESTRUCTURING EFFORT

PHASE II RESULTS OF BRADYCOR POSITIVE FOR HEAD TRAUMA

ANOTHER DAVID BLECH CASUALTY . . . PARNASSUS LAYS OFF ITS WORK FORCE,

IMMUNOLOGISTS UPBEAT AT START OF CANCER VACCINE SYMPOSIUM

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...